Genmab A/S Stock

Genmab A/S EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of Genmab A/S (GMAB.CO) as of Aug 7, 2026 is 17.23. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was 12.37 — a change of 39.33% (higher).

EV/OCF

17.23

YoY

39.33%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of Genmab A/S is 2026 17.23 . EV/OCF (Enterprise Value to Operating Cash Flow) of Genmab A/S was 2025 12.37 . It decreases by 39.33% higher compared to the previous year.
Access this data via the Eulerpool API

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

EV/OCF (Enterprise Value to Operating Cash Flow) of Genmab A/S is 17.23 in 2026.

EV/OCF (Enterprise Value to Operating Cash Flow) of Genmab A/S changed from 12.37 to 17.23, representing a 39.33% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) Genmab A/S since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s Genmab A/S with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Genmab A/S

All Key Metrics — Genmab A/S